Pura Vida Investments
Latest statistics and disclosures from Pura Vida Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Spdr S&p 500 Etf Tr option, Powershares Qqq Etf Put Opt 01/19 154.0 put, Ishares Tr Index option, ESTA, Ark Etf Tr put, and represent 33.09% of Pura Vida Investments's stock portfolio.
- Added to shares of these 10 stocks: Spdr S&p 500 Etf Tr option (+$417M), Powershares Qqq Etf Put Opt 01/19 154.0 put (+$292M), Ishares Tr Index option (+$184M), Ark Etf Tr put (+$79M), Medtronic Plc put (+$62M), Ark Etf Tr (+$56M), Intellia Therapeutics Inc call (+$49M), Spdr S&p Oil & Gas Exp & Pr put (+$47M), Intellia Therapeutics Inc put (+$40M), Hca Holdings Inc cmn (+$38M).
- Started 117 new stock positions in Spdr S&p 500 Etf Tr option, GHRS, Trupanion, Arcus Biosciences Inc call, Intellia Therapeutics Inc call, NEUROCRINE BIOSCIENCES INC CMN Stock cmn, Compugen Ltd ord, Lexicon Pharmaceuticals, Compugen Ltd ord, Fibrogen.
- Reduced shares in these 10 stocks: QQQ (-$343M), , IWM (-$308M), , , ARKK (-$75M), ARKG (-$62M), IBB (-$53M), , .
- Sold out of its positions in ARKK, ARKG, ABT, ABCL, ACAD, ACRS, Alexion Pharmaceuticals, ALGN, ALPN, ALT.
- Pura Vida Investments was a net seller of stock by $-405M.
- Pura Vida Investments has $3.2B in assets under management (AUM), dropping by -8.44%.
- Central Index Key (CIK): 0001590144
Tip: Access up to 7 years of quarterly data
Positions held by Pura Vida Investments consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Pura Vida Investments
Companies in the Pura Vida Investments portfolio as of the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Put Put Option | 13.0 | $417M | NEW | 975k | 428.06 | |
| Invesco Qqq Tr Put Put Option | 9.1 | $292M | NEW | 825k | 354.43 | |
| Ishares Tr Put Put Option | 5.7 | $184M | NEW | 800k | 229.37 | |
| Establishment Labs Holdings Ord (ESTA) | 2.8 | $92M | -4% | 1.0M | 87.34 | |
| Ark Etf Tr Put Put Option | 2.4 | $79M | NEW | 600k | 130.78 | |
| Oncocyte (OCX) | 2.2 | $70M | 12M | 5.74 | ||
| Viewray (VRAY) | 2.2 | $70M | +9% | 11M | 6.60 | |
| Nanostring Technologies (NSTG) | 2.1 | $69M | +4% | 1.1M | 64.79 | |
| Medtronic Put Put Option | 1.9 | $62M | NEW | 500k | 124.13 | |
| Ark Etf Tr Put Put Option | 1.7 | $56M | NEW | 600k | 92.50 | |
| Inovalon Hldgs Com Cl A (INOV) | 1.7 | $55M | -17% | 1.6M | 34.08 | |
| Intellia Therapeutics Call Call Option | 1.5 | $49M | NEW | 302k | 161.91 | |
| Spdr Ser Tr Put Put Option | 1.5 | $47M | NEW | 350k | 135.40 | |
| AtriCure (ATRC) | 1.4 | $45M | -15% | 565k | 79.33 | |
Setup an alertPura Vida Investments will file the next quarterly 13-HR in about 1 months. Would you like to be notified? |
||||||
| Intellia Therapeutics Put Put Option | 1.2 | $40M | NEW | 247k | 161.91 | |
| Inspire Med Sys (INSP) | 1.2 | $39M | 204k | 193.26 | ||
| Hca Healthcare Put Put Option | 1.2 | $38M | NEW | 185k | 206.74 | |
| Select Sector Spdr Tr Put Put Option | 1.2 | $38M | NEW | 300k | 125.95 | |
| Intellia Therapeutics (NTLA) | 1.1 | $35M | -44% | 215k | 161.91 | |
| Illumina Put Put Option | 1.0 | $32M | NEW | 68k | 473.21 | |
| ICU Medical, Incorporated (ICUI) | 1.0 | $31M | -23% | 150k | 205.80 | |
| First Tr Exchange Traded Put Put Option | 0.9 | $29M | NEW | 250k | 117.11 | |
| Cutera (CUTR) | 0.9 | $29M | +19% | 597k | 49.03 | |
| Intuitive Surgical Call Call Option | 0.9 | $28M | NEW | 30k | 919.63 | |
| Staar Surgical Com Par $0.01 (STAA) | 0.8 | $27M | -38% | 177k | 152.50 | |
| Pulmonx Corp (LUNG) | 0.8 | $26M | +34% | 595k | 44.12 | |
| Danaher Corporation Put Put Option | 0.8 | $25M | NEW | 92k | 268.36 | |
| Natera (NTRA) | 0.8 | $25M | -12% | 217k | 113.53 | |
| Atai Life Sciences Nv SHS (ATAI) | 0.7 | $23M | NEW | 1.4M | 16.94 | |
| Abbott Labs Call Call Option | 0.7 | $23M | NEW | 200k | 115.93 | |
| Hydrofarm Holdings Group Ord (HYFM) | 0.7 | $23M | -13% | 388k | 59.11 | |
| Thermo Fisher Scientific Put Put Option | 0.7 | $23M | NEW | 45k | 504.47 | |
| R1 Rcm (RCM) | 0.7 | $21M | 960k | 22.24 | ||
| Organogenesis Hldgs (ORGO) | 0.7 | $21M | -14% | 1.3M | 16.62 | |
| Perkinelmer Put Put Option | 0.6 | $20M | NEW | 128k | 154.41 | |
| Apria (APR) | 0.6 | $20M | -8% | 700k | 28.00 | |
| Livanova SHS (LIVN) | 0.6 | $19M | -8% | 230k | 84.11 | |
| Outset Med (OM) | 0.6 | $19M | +2% | 373k | 49.98 | |
| Quanterix Ord (QTRX) | 0.6 | $18M | +26% | 307k | 58.66 | |
| Amyris Com New (AMRS) | 0.5 | $18M | +26% | 1.1M | 16.37 | |
| Medavail Holdings Ord (MDVL) | 0.5 | $17M | -41% | 1.4M | 12.25 | |
| Pacific Biosciences of California (PACB) | 0.5 | $17M | -19% | 472k | 34.97 | |
| Quotient SHS (QTNT) | 0.5 | $16M | +105% | 4.5M | 3.64 | |
| Irhythm Technologies Call Call Option | 0.5 | $16M | NEW | 236k | 66.35 | |
| Agilon Health (AGL) | 0.5 | $16M | NEW | 384k | 40.57 | |
| Privia Health Group (PRVA) | 0.5 | $15M | NEW | 346k | 44.37 | |
| Eli Lilly & Co. (LLY) | 0.5 | $15M | NEW | 66k | 229.51 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.5 | $15M | NEW | 537k | 27.64 | |
| MiMedx (MDXG) | 0.5 | $15M | +2% | 1.2M | 12.51 | |
| Universal Hlth Svcs Put Put Option | 0.4 | $14M | NEW | 98k | 146.43 | |
| Cutera Call Call Option | 0.4 | $14M | NEW | 293k | 49.03 | |
| Vaneck Vectors Etf Tr Put Put Option | 0.4 | $14M | NEW | 195k | 73.06 | |
| Icu Med Call Call Option | 0.4 | $14M | NEW | 69k | 205.79 | |
| Cm Life Sciences Ii Unit 02/25/2028 | 0.4 | $14M | 1.0M | 13.45 | ||
| Stereotaxis Com New (STXS) | 0.4 | $14M | -10% | 1.5M | 9.64 | |
| Schrodinger (SDGR) | 0.4 | $14M | 178k | 75.61 | ||
| Stryker Corporation Put Put Option | 0.4 | $13M | NEW | 50k | 259.74 | |
| 10x Genomics Put Put Option | 0.4 | $13M | NEW | 65k | 195.82 | |
| 10x Genomics Cl A Com (TXG) | 0.4 | $13M | -8% | 65k | 195.82 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.4 | $12M | +18% | 303k | 40.86 | |
| Tela Bio (TELA) | 0.4 | $12M | +79% | 758k | 16.11 | |
| Qiagen Nv Put Put Option | 0.4 | $12M | NEW | 250k | 48.38 | |
| Personalis Ord (PSNL) | 0.4 | $12M | -13% | 475k | 25.30 | |
| Pfizer Put Put Option | 0.4 | $12M | NEW | 300k | 39.16 | |
| Dex (DXCM) | 0.3 | $11M | -72% | 26k | 426.99 | |
| Invacare Corporation (IVC) | 0.3 | $11M | -25% | 1.4M | 8.07 | |
| Codexis (CDXS) | 0.3 | $11M | 484k | 22.66 | ||
| Inovalon Hldgs Call Call Option | 0.3 | $11M | NEW | 320k | 34.08 | |
| Dexcom Put Put Option | 0.3 | $11M | NEW | 25k | 427.00 | |
| Profound Med Corp Com New (PROF) | 0.3 | $11M | -16% | 644k | 16.36 | |
| Misonix (MSON) | 0.3 | $11M | -6% | 472k | 22.18 | |
| Biogen Call Call Option | 0.3 | $10M | NEW | 30k | 346.27 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 0.3 | $10M | -21% | 291k | 34.42 | |
| Talkspace (TALK) | 0.3 | $10M | NEW | 1.2M | 8.31 | |
| Apyx Medical Corporation (APYX) | 0.3 | $9.8M | 952k | 10.31 | ||
| Curevac N V Call Call Option | 0.3 | $9.7M | NEW | 132k | 73.48 | |
| Bioventus Com Cl A (BVS) | 0.3 | $9.6M | -37% | 545k | 17.60 | |
| Zoetis Put Put Option | 0.3 | $9.3M | NEW | 50k | 186.36 | |
| Curevac N V Put Put Option | 0.3 | $9.3M | NEW | 127k | 73.48 | |
| Irhythm Technologies (IRTC) | 0.3 | $9.3M | NEW | 140k | 66.35 | |
| Fulgent Genetics Put Put Option | 0.3 | $9.2M | NEW | 100k | 92.23 | |
| Intersect Ent (XENT) | 0.3 | $9.1M | -54% | 531k | 17.09 | |
| Codex Dna (DNAY) | 0.3 | $8.8M | NEW | 400k | 22.00 | |
| Gh Research Ordinary Shares (GHRS) | 0.3 | $8.7M | NEW | 400k | 21.73 | |
| Zymergen (ZY) | 0.3 | $8.6M | NEW | 215k | 40.01 | |
| Alpha Teknova (TKNO) | 0.3 | $8.3M | NEW | 350k | 23.73 | |
| Seer Com Cl A (SEER) | 0.3 | $8.3M | -3% | 253k | 32.78 | |
| Guardant Health (GH) | 0.3 | $8.2M | -36% | 66k | 124.18 | |
| Zimmer Holdings (ZBH) | 0.3 | $8.0M | -66% | 50k | 160.82 | |
| Novocure Put Put Option | 0.2 | $7.7M | NEW | 35k | 221.82 | |
| Abbvie Call Call Option | 0.2 | $7.4M | NEW | 66k | 112.64 | |
| The Beauty Health Company Com Cl A (SKIN) | 0.2 | $7.4M | NEW | 440k | 16.80 | |
| Bionano Genomics (BNGO) | 0.2 | $7.3M | 1.0M | 7.33 | ||
| Compass Pathways Sponsored Ads (CMPS) | 0.2 | $7.3M | +37% | 190k | 38.15 | |
| CVRX (CVRX) | 0.2 | $7.0M | NEW | 250k | 28.00 | |
| Clover Health Investments Put Put Option | 0.2 | $6.7M | NEW | 500k | 13.32 | |
| Abm Inds Put Put Option | 0.2 | $6.7M | NEW | 150k | 44.35 | |
| Quest Diagnostics Put Put Option | 0.2 | $6.6M | NEW | 50k | 131.98 | |
| Nanostring Technologies Call Call Option | 0.2 | $6.5M | NEW | 100k | 64.79 | |
| Mirati Therapeutics (MRTX) | 0.2 | $6.4M | +30% | 40k | 161.53 | |
| 908 Devices (MASS) | 0.2 | $6.2M | +8% | 161k | 38.75 | |
| Cullinan Oncology (CGEM) | 0.2 | $6.2M | +11% | 241k | 25.75 | |
| Exact Sciences Corp Put Put Option | 0.2 | $6.1M | NEW | 49k | 124.31 | |
| Quanterix Corp Call Call Option | 0.2 | $5.9M | NEW | 100k | 58.66 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.2 | $5.7M | 535k | 10.72 | ||
| Fibrogen Put Put Option | 0.2 | $5.7M | NEW | 213k | 26.63 | |
| Regeneron Pharmaceuticals (REGN) | 0.2 | $5.6M | NEW | 10k | 558.50 | |
| Amicus Therapeutics Call Call Option | 0.2 | $5.5M | NEW | 567k | 9.64 | |
| Neuropace (NPCE) | 0.2 | $5.5M | NEW | 229k | 23.79 | |
| Icad Com New (ICAD) | 0.2 | $5.4M | -20% | 310k | 17.31 | |
| Avita Therapeutics (RCEL) | 0.2 | $5.3M | -32% | 259k | 20.52 | |
| Cortexyme Call Call Option | 0.2 | $5.3M | NEW | 100k | 53.00 | |
| Cm Life Sciences Iii Unit 04/30/2028 (CMLTU) | 0.2 | $5.3M | NEW | 483k | 10.95 | |
| Research Alliance Corp Ii Com Cl A (RACB) | 0.2 | $5.3M | -2% | 520k | 10.14 | |
| Fibrogen Call Call Option | 0.2 | $5.2M | NEW | 195k | 26.63 | |
| Cytokinetics Note 4.000%11/1 (Principal) | 0.2 | $5.2M | 25k | 207.12 | ||
| Hologic Put Put Option | 0.2 | $5.0M | NEW | 75k | 66.72 | |
| Teladoc Health Put Put Option | 0.2 | $5.0M | NEW | 30k | 166.30 | |
| Nevro (NVRO) | 0.2 | $5.0M | NEW | 30k | 165.80 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.2 | $4.8M | +60% | 91k | 53.20 | |
| Glaukos (GKOS) | 0.1 | $4.7M | -40% | 55k | 84.84 | |
| Caremax Com Cl A (CMAX) | 0.1 | $4.7M | NEW | 362k | 12.90 | |
| Akoya Biosciences (AKYA) | 0.1 | $4.6M | NEW | 240k | 19.34 | |
| Turning Pt Brands (TPB) | 0.1 | $4.6M | -53% | 101k | 45.77 | |
| Viewray Call Call Option | 0.1 | $4.6M | NEW | 700k | 6.60 | |
| Neurocrine Biosciences Call Call Option | 0.1 | $4.6M | NEW | 47k | 97.31 | |
| ImmunoGen (IMGN) | 0.1 | $4.5M | -14% | 689k | 6.59 | |
| Corcept Therapeutics Call Call Option | 0.1 | $4.4M | NEW | 200k | 22.00 | |
| Lyra Therapeutics (LYRA) | 0.1 | $4.4M | NEW | 543k | 8.03 | |
| Singular Genomics Systems In (OMIC) | 0.1 | $4.3M | NEW | 156k | 27.48 | |
| Establishment Labs Hldgs Call Call Option | 0.1 | $4.3M | NEW | 49k | 87.34 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $3.9M | +50% | 703k | 5.50 | |
| Deciphera Pharmaceuticals In Call Call Option | 0.1 | $3.6M | NEW | 100k | 36.61 | |
| Verve Therapeutics (VERV) | 0.1 | $3.6M | NEW | 59k | 60.24 | |
| Celldex Therapeutics Com New (CLDX) | 0.1 | $3.5M | -35% | 105k | 33.44 | |
| Glaukos Corp Put Put Option | 0.1 | $3.4M | NEW | 40k | 84.83 | |
| Beam Therapeutics (BEAM) | 0.1 | $3.2M | NEW | 25k | 128.72 | |
| Immunogen Call Call Option | 0.1 | $3.2M | NEW | 488k | 6.59 | |
| Corbus Pharmaceuticals Hldgs Call Call Option | 0.1 | $3.1M | NEW | 1.7M | 1.83 | |
| Arcutis Biotherapeutics (ARQT) | 0.1 | $3.1M | -21% | 114k | 27.29 | |
| Doximity Cl A (DOCS) | 0.1 | $2.9M | NEW | 50k | 58.20 | |
| Trupanion Put Put Option | 0.1 | $2.9M | NEW | 25k | 115.12 | |
| Vincerx Pharma Com New (VINC) | 0.1 | $2.8M | +43% | 214k | 12.99 | |
| Twist Bioscience Corp Put Put Option | 0.1 | $2.7M | NEW | 20k | 133.25 | |
| Lucira Health (LHDX) | 0.1 | $2.7M | NEW | 400k | 6.64 | |
| Dynamics Special Purpose Cor Class A Com (DYNS) | 0.1 | $2.5M | NEW | 250k | 9.94 | |
| Arvinas Ord (ARVN) | 0.1 | $2.4M | 32k | 77.01 | ||
| Arcus Biosciences Call Call Option | 0.1 | $2.4M | NEW | 88k | 27.45 | |
| Abg Acquisition Corp I Cl A Shs (ABGI) | 0.1 | $2.4M | 243k | 9.80 | ||
| Monte Rosa Therapeutics (GLUE) | 0.1 | $2.3M | NEW | 100k | 22.70 | |
| Personalis Call Call Option | 0.1 | $2.2M | NEW | 88k | 25.30 | |
| Forte Biosciences (FBRX) | 0.1 | $2.2M | -42% | 66k | 33.62 | |
| Frontier Acquisition Corp Unit 03/01/2026 (FRONU) | 0.1 | $2.2M | -27% | 217k | 10.00 | |
| 5 01 Acquisition Corp Com Cl A (FVAM) | 0.1 | $2.2M | 216k | 9.97 | ||
| Venus Concept (VERO) | 0.1 | $2.1M | -2% | 687k | 3.11 | |
| Novavax Com New (NVAX) | 0.1 | $2.1M | NEW | 10k | 212.30 | |
| Nautilus Biotechnology (NAUT) | 0.1 | $2.1M | NEW | 207k | 10.10 | |
| Kura Oncology (KURA) | 0.1 | $2.1M | -19% | 100k | 20.85 | |
| Compugen Call Call Option | 0.1 | $2.1M | NEW | 249k | 8.28 | |
| Cyclerion Therapeutics (CYCN) | 0.1 | $2.0M | NEW | 508k | 3.90 | |
| Greenlane Hldgs Cl A (GNLN) | 0.1 | $1.8M | 408k | 4.47 | ||
| Compugen Put Put Option | 0.1 | $1.6M | NEW | 195k | 8.28 | |
| Priveterra Acquisition Corp Unit 99/99/9999 (PMGMU) | 0.1 | $1.6M | -23% | 162k | 9.96 | |
| Repare Therapeutics Ord (RPTX) | 0.0 | $1.6M | -4% | 51k | 31.19 | |
| Travere Therapeutics (TVTX) | 0.0 | $1.5M | -16% | 105k | 14.59 | |
| Phathom Pharmaceuticals (PHAT) | 0.0 | $1.5M | -29% | 45k | 33.84 | |
| Chardan Healthcr Acqstn 2 | 0.0 | $1.5M | 154k | 9.92 | ||
| Sierra Oncology Com New (SRRA) | 0.0 | $1.5M | -2% | 75k | 19.48 | |
| Vaxart Call Call Option | 0.0 | $1.5M | NEW | 195k | 7.49 | |
| Poseida Therapeutics I (PSTX) | 0.0 | $1.4M | -39% | 143k | 10.02 | |
| Lexicon Pharmaceuticals Call Call Option | 0.0 | $1.4M | NEW | 301k | 4.59 | |
| Avadel Pharmaceuticals Call Call Option | 0.0 | $1.3M | NEW | 195k | 6.73 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 0.0 | $1.2M | -24% | 176k | 6.73 | |
| Bctg Acquisition Corp | 0.0 | $1.1M | NEW | 99k | 11.38 | |
| Compass Pathways Call Call Option | 0.0 | $1.1M | NEW | 29k | 38.16 | |
| Essa Pharma Com New (EPIX) | 0.0 | $1.1M | -70% | 39k | 28.58 | |
| Logicbio Therapeutics (LOGC) | 0.0 | $1.1M | 249k | 4.44 | ||
| Health Sciences Acq Corp 2 Ord Shs (HSAQ) | 0.0 | $1.1M | 108k | 10.20 | ||
| Chinook Therapeutics (KDNY) | 0.0 | $1.0M | NEW | 74k | 14.13 | |
| Medtech Acquisition Corp Unit 12/18/2025 (MTACU) | 0.0 | $1.0M | -64% | 104k | 10.02 | |
| Finch Therapeutics (FNCH) | 0.0 | $1.0M | -55% | 72k | 14.07 | |
| Altimmune Call Call Option | 0.0 | $960k | NEW | 98k | 9.85 | |
| Healthcor Catalio Acqu Corp Cl A Shs (HCAQ) | 0.0 | $958k | 97k | 9.85 | ||
| Exelixis (EXEL) | 0.0 | $943k | -22% | 52k | 18.21 | |
| Cyclacel Pharmaceuticals (CYCC) | 0.0 | $931k | -42% | 157k | 5.92 | |
| Krystal Biotech Put Put Option | 0.0 | $850k | NEW | 13k | 68.00 | |
| Gossamer Bio (GOSS) | 0.0 | $801k | 99k | 8.12 | ||
| Yumanity Therapeutics (YMTX) | 0.0 | $794k | 68k | 11.64 | ||
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.0 | $794k | -21% | 81k | 9.79 | |
| Silver Spike Acquisitn Corp Unit 02/26/2026 (SPKBU) | 0.0 | $783k | -83% | 78k | 10.10 | |
| Exagen (XGN) | 0.0 | $772k | -84% | 52k | 14.99 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.0 | $717k | NEW | 34k | 21.20 | |
| Seres Therapeutics (MCRB) | 0.0 | $716k | NEW | 30k | 23.87 | |
| Theravance Biopharma (TBPH) | 0.0 | $708k | NEW | 49k | 14.52 | |
| Aveo Pharmaceuticals Com New (AVEO) | 0.0 | $643k | NEW | 98k | 6.59 | |
| Cytomx Therapeutics (CTMX) | 0.0 | $638k | -50% | 101k | 6.33 | |
| Mereo Biopharma Group Ads (MREO) | 0.0 | $623k | +95% | 197k | 3.17 | |
| Talkspace *w Exp 06/21/202 (TALKW) | 0.0 | $602k | NEW | 448k | 1.35 | |
| Clovis Oncology (CLVS) | 0.0 | $566k | NEW | 98k | 5.80 | |
| Longeveron Llc Ordinary Shares - Class A (LGVN) | 0.0 | $546k | NEW | 67k | 8.13 | |
| Tarsus Pharmaceuticals (TARS) | 0.0 | $484k | NEW | 17k | 29.01 | |
| Kalvista Pharmaceuticals (KALV) | 0.0 | $478k | 20k | 23.95 | ||
| Gossamer Bio Note 5.000% 6/0 (Principal) | 0.0 | $404k | 5.0k | 80.80 | ||
| Wm Technology *w Exp 06/16/202 (MAPSW) | 0.0 | $318k | NEW | 50k | 6.36 | |
| Arcus Biosciences Put Put Option | 0.0 | $305k | NEW | 11k | 27.48 | |
| Iveric Bio (ISEE) | 0.0 | $303k | NEW | 48k | 6.30 | |
| Lexicon Pharmaceuticals Put Put Option | 0.0 | $291k | NEW | 63k | 4.60 | |
| Lipocine Call Call Option | 0.0 | $280k | NEW | 200k | 1.40 | |
| Tricida (TCDA) | 0.0 | $240k | NEW | 56k | 4.32 | |
| Sensei Biotherapeutics (SNSE) | 0.0 | $208k | -66% | 23k | 9.20 | |
| Tuatara Capital Acquisitn Unit 99/99/9999 (TCACU) | 0.0 | $204k | 20k | 10.20 | ||
| Savara (SVRA) | 0.0 | $169k | 99k | 1.70 | ||
| Achieve Life Sciences (ACHV) | 0.0 | $153k | NEW | 17k | 9.00 | |
| Chardan Healthcr Acqstn 2 *w Exp 03/05/202 | 0.0 | $99k | 154k | 0.64 | ||
| Lipocine (LPCN) | 0.0 | $77k | NEW | 55k | 1.41 | |
| Kintara Therapeutics (KTRA) | 0.0 | $64k | NEW | 28k | 2.27 | |
Past Filings by Pura Vida Investments
SEC 13F filings are viewable for Pura Vida Investments going back to 2014
- Pura Vida Investments 2021 Q2 filed Aug. 16, 2021
- Pura Vida Investments 2021 Q1 filed May 12, 2021
- Pura Vida Investments 2020 Q4 filed Feb. 16, 2021
- Pura Vida Investments 2019 Q1 restated filed Feb. 12, 2021
- Pura Vida Investments 2020 Q1 restated filed Feb. 12, 2021
- Pura Vida Investments 2019 Q2 restated filed Feb. 12, 2021
- Pura Vida Investments 2020 Q2 restated filed Feb. 12, 2021
- Pura Vida Investments 2019 Q3 restated filed Feb. 12, 2021
- Pura Vida Investments 2019 Q4 restated filed Feb. 12, 2021
- Pura Vida Investments 2017 Q4 restated filed Feb. 11, 2021
- Pura Vida Investments 2018 Q1 restated filed Feb. 11, 2021
- Pura Vida Investments 2018 Q2 restated filed Feb. 11, 2021
- Pura Vida Investments 2018 Q3 restated filed Feb. 11, 2021
- Pura Vida Investments 2018 Q4 restated filed Feb. 11, 2021
- Pura Vida Investments 2017 Q3 restated filed Feb. 11, 2021
- Pura Vida Investments 2020 Q3 filed Nov. 16, 2020